Executive Leadership Position Strengthens Company’s Dedication to Excellence in Development of Investigator Initiated Trials

MORRISVILLE, N.C. (Business Wire) APRIL 24, 2012 – Clinipace Worldwide, a global digital clinical research organization (dCRO), today announced company executive, Ran Frenkel, RPh, Vice President, International Business Development, was recently elected to the 2012-2013 Investigator Initiated Sponsored Research Association (IISRA) Board of Directors. Frenkel will serve as the organization’s vice president.

The IISRA is a global association dedicated to the support of independent scientific research that may one day lead to innovative therapies and improved quality of life for patients. The organization supports members through the development and implementation of educational activities, professional knowledge standards, and ethical practices. With approximately 300 members, the IISRA consists of professionals from the pharma, biotech, device, academia, CRO, technology, and consulting industries.

“As a digital clinical research organization, it is one of our primary missions to do our part in promoting excellence in the development of investigator initiated trials and sponsored research programs,” commented Frenkel. “That being said, it’s an honor to serve on such a distinguished panel of dedicated professionals.”

About Clinipace Worldwide

As a global full-service digital contract research organization (dCRO), we have pioneered an innovative technology-amplified research model to serve the unique needs of emerging and mid-tier biopharmaceutical and medical device firms. Powered by TEMPO™, our proprietary eClinical platform, our team of experts brings extensive therapeutic knowledge and insight into assisting life science firms in developing and executing regulatory strategies, clinical development, and post-approval research to ensure a successful drug and medical device development program. We have managed over 600 global contract research and regulatory projects. Clinipace Worldwide is headquartered in Research Triangle Park, North Carolina with offices in Boulder, Overland Park, Zurich, Munich, Tel-Aviv, Sao Paulo, Buenos Aires, Lima, and New Delhi. For more information visit our website at www.clinipace.com.